Article
State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia
2 Feb 2024
Abstract excerpt
Chronic myeloid leukemia (CML) is initiated and maintained by BCR::ABL which is clinically targeted using tyrosine kinase inhibitors (TKIs). TKIs can induce long-term remission but are also not curative. Thus, CML is an ideal system to test our hypothesis that transcriptome-based state-transition models accurately predict cancer evolution and treatment response. We collected time-sequential blood samples from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
